Corpus Engine Towards a reproducible .science file.
← All .science files

pmid:37990309

A real-world study and network pharmacology analysis of EGFR-TKIs combined with ZLJT to delay drug resistance in advanced lung adenocarcinoma.

Xue Han · Lan Liang · Chenming He · Qinyou Ren · Jialin Su · Liang Cao · Jin Zheng

BMC complementary medicine and therapies · 2023 doi:10.1186/s12906-023-04213-3

Paper

complete

Experiment

complete

Data

partial

Analysis

partial

Execution

absent

Execution evidence has not yet been added to this .science file. Explore its methods, data and open questions to plan the next step.
Record details sci_version · id · kind · revision · content_hash · schema · created_at · updated_at · generator
id
pmid:37990309
kind
science-record
content_hash
sha256:96a9e781903325cdd447e0c5640895b41dbed65402b495d05e5e40eeddb6a763
schema
https://corpus.bntrg.co.uk/sci/1.0/sci.schema.json
created_at
2026-11-01T19:02:55Z
updated_at
2026-11-01T22:10:43Z
generator object · 2 fields
name
corpus-assay-engine
run_id
reading-sci-2026-11-01
paper object · 10 fields
state
complete
title
A real-world study and network pharmacology analysis of EGFR-TKIs combined with ZLJT to delay drug resistance in advanced lung adenocarcinoma.
doi
10.1186/s12906-023-04213-3
pmid
37990309
authors array · 7 items
[0]
Xue Han
[1]
Lan Liang
[2]
Chenming He
[3]
Qinyou Ren
[4]
Jialin Su
[5]
Liang Cao
[6]
Jin Zheng
journal
BMC complementary medicine and therapies
year
2023
abstract
OBJECTIVE: This study aimed to explore the efficacy and safety of combining epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) with ZiLongJin Tablet (ZLJT) in delaying acquired resistance in advanced EGFR-mutant lung adenocarcinoma (LUAD) patients. Furthermore, we employed network pharmacology and molecular docking techniques to investigate the underlying mechanisms. METHODS: A retrospective comparative study was conducted on stage IIIc/IV LUAD patients treated with EGFR-TKIs alone or in combination with ZLJT at the Second Affiliated Hospital of the Air Force Medical University between January 1, 2017, and May 1, 2023. The study evaluated the onset of TKI resistance, adverse reaction rates, safety indicators (such as aspartate aminotransferase, alanine aminotransferase, and creatinine), and inflammatory markers (neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio) to investigate the impact of EGFR-TKI combined with ZLJT on acquired resistance and prognostic indicators. Additionally, we utilized the Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform, the Bioinformatics Analysis Tool for Molecular Mechanism of Traditional Chinese Medicine, PubChem, UniProt, and Swiss Target Prediction databases to identify the active ingredients and targets of ZLJT. We obtained differentially expressed genes related to EGFR-TKI sensitivity and resistance from the Gene Expression Omnibus database using the GSE34228 dataset, which included sensitive (n = 26) and resistant (n = 26) PC9 cell lines. The "limma" package in R software was employed to detect DEGs. Based on this, we constructed a protein‒protein interaction network, performed gene ontology and KEGG enrichment analyses, and conducted pathway network analysis to elucidate the correlation between the active ingredients in ZLJT and signaling pathways. Finally, molecular docking was performed using AutoDockVina, PYMOL 2.2.0, and Discovery Studio Client v19.1.0 software to simulate spatial and energy matching during the recognition process between predicted targets and their corresponding compounds. RESULTS: (1) A total of 89 patients were included, with 40 patients in the EGFR-TKI combined with ZLJT group (combination group) and 49 patients in the EGFR-TKI alone group (monotherapy group). The baseline characteristics of the two groups were comparable. There was a significant difference in the onset of resistance between the combination group and the monotherapy group (P < 0.01). Compared to the monotherapy group, the combination group showed a prolongation of 3.27 months in delayed acquired resistance. There was also a statistically significant difference in the onset of resistance to first-generation TKIs between the two groups (P < 0.05). (2) In terms of safety analysis, the incidence of adverse reactions related to EGFR-TKIs was 12.5% in the combination group and 14.3% in the monotherapy group, but this difference was not statistically significant (P > 0.05). There were no statistically significant differences in serum AST, ALT, CREA, TBIL, ALB and BUN levels between the two groups after medication (P > 0.05). (3) Regarding inflammatory markers, there were no statistically significant differences in the changes in neutrophil-to-lymphocyte Ratio(NLR) and Platelet-to-lymphocyte Ratio(PLR) values before and after treatment between the two groups (P > 0.05). (4) Network pharmacology analysis identified 112 active ingredients and 290 target genes for ZLJT. From the GEO database, 2035 differentially expressed genes related to resistant LUAD were selected, and 39 target genes were obtained by taking the intersection. A "ZLJT-compound-target-disease" network was successfully constructed using Cytoscape 3.7.0. GO enrichment analysis revealed that ZLJT mainly affected biological processes such as adenylate cyclase-modulating G protein-coupled receptor. In terms of cellular components, ZLJT was associated with the cell projection membrane. The molecular function primarily focused on protein heterodimerization activity. KEGG enrichment analysis indicated that ZLJT exerted its antitumor and anti-drug resistance effects through pathways such as the PI3K-Akt pathway. Molecular docking showed that luteolin had good binding activity with FOS (-9.8 kJ/mol), as did tanshinone IIA with FOS (-9.8 kJ/mol) and quercetin with FOS (-8.7 kJ/mol). CONCLUSION: ZLJT has potential antitumor progression effects. For patients with EGFR gene-mutated non-small cell LUAD, combining ZLJT with EGFR-TKI treatment can delay the occurrence of acquired resistance. The underlying mechanisms may involve altering signal transduction pathways, blocking the tumor cell cycle, inhibiting tumor activity, enhancing cellular vitality, and improving the bioavailability of combination therapy. The combination of EGFR-TKI and ZLJT represents an effective approach for the treatment of tumors using both Chinese and Western medicine.
claims array · 3 items
[0] object · 6 fields
id
claim-method
statement
For continuous data that did not follow a normal distribution, the median (interquartile range) was used, and nonparametric tests, such as the Mann‒Whitney U test, were performed.
kind
methodological
target
null
evidence array · 1 item
[0] object · 3 fields
asset
source:pmid:37990309
locator
sections[17] "Statistical analysis of clinical data" paragraph 2
quote
For continuous data that did not follow a normal distribution, the median (interquartile range) was used, and nonparametric tests, such as the Mann‒Whitney U test, were performed.
state
complete
[1] object · 6 fields
id
claim-data-access
statement
The original contributions presented in the study are included in the article/Supplementary Materials. Further inquiries can be directed to the corresponding authors.
kind
methodological
target
null
evidence array · 1 item
[0] object · 3 fields
asset
source:pmid:37990309
locator
sections[38] "notes" paragraph 1
quote
The original contributions presented in the study are included in the article/Supplementary Materials. Further inquiries can be directed to the corresponding authors.
state
complete
[2] object · 6 fields
id
claim-target-result
statement
Compared with EGFR-TKI monotherapy, combination therapy with ZLJT prolonged the time to acquired resistance by 3.27 months (P < 0.01).
kind
qualitative
target
null
evidence array · 1 item
[0] object · 3 fields
asset
source:pmid:37990309
locator
sections[0] "Abstract" paragraph 3
quote
Compared to the monotherapy group, the combination group showed a prolongation of 3.27 months in delayed acquired resistance.
state
complete
gaps array · 0 items
experiment object · 8 fields
state
complete
objective
Compared with EGFR-TKI monotherapy, combination therapy with ZLJT prolonged the time to acquired resistance by 3.27 months (P < 0.01).
steps array · 3 items
[0] object · 13 fields
id
read_published_estimate
order
1
name
Read the published estimate from the source
kind
other
state
complete
blocked_on
null
description
The claim, method and evidence span published with the source article.
parameters object · 0 fields
inputs array · 1 item
[0]
source:pmid:37990309
outputs array · 1 item
[0]
the published estimate and its evidence
instruments array · 0 items
reagents array · 0 items
[1] object · 13 fields
id
obtain_source_data
order
2
name
Obtain the source data from the named repository
kind
data-preparation
state
complete
blocked_on
null
description
The GEO series accession resolves and its sample accessions are listed. This lane did not download the dataset or read its licence.
parameters object · 0 fields
inputs array · 1 item
[0]
data:geo:GSE34228
outputs array · 1 item
[0]
the source data with its repository provenance
instruments array · 0 items
reagents array · 0 items
[2] object · 13 fields
id
run_analysis
order
3
name
Run the published analysis
kind
analysis
state
complete
blocked_on
null
description
Apply the paper's statistical method to the resolved series and compare the result with the published target.
parameters object · 0 fields
inputs array · 1 item
[0]
data:geo:GSE34228
outputs array · 1 item
[0]
the replicated result and its comparison
instruments array · 0 items
reagents array · 0 items
materials array · 0 items
instruments array · 0 items
reagents array · 0 items
conditions object · 0 fields
gaps array · 0 items
data object · 3 fields
state
partial
assets array · 2 items
[0] object · 15 fields
id
source:pmid:37990309
role
manuscript
format
xml
media_type
application/xml
uri
https://doi.org/10.1186/s12906-023-04213-3
sha256
sha256:cb4e5f7efa84c91c3b43b2703b6dc67dce0a93aa0d30fb12ecd1331b2b50e201
bytes
63318
access
open
state
resolved
reader
null
reader_status
reader_required
identifier
10.1186/s12906-023-04213-3
version
null
note
Full article fetched from PMC; the checksum covers the rendered section body, not the original XML bytes.
structure object · 4 fields
pmcid
PMC10664478
source
europe_pmc_fulltext
coverage
whole_body_without_references
text_hash_scope
rendered_section_body
[1] object · 15 fields
id
data:geo:GSE34228
role
raw
format
geo-series
media_type
application/vnd.ncbi.geo-series+json
uri
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE34228
sha256
null
bytes
null
access
open
state
resolved
reader
null
reader_status
reader_required
identifier
GSE34228
version
null
note
The original contributions presented in the study are included in the article/Supplementary Materials. Further inquiries can be directed to the corresponding authors.
structure object · 15 fields
repository
GEO
access_route
GEO accession URL
access_statement_verbatim
The original contributions presented in the study are included in the article/Supplementary Materials. Further inquiries can be directed to the corresponding authors.
access_statement_kind
data_availability_statement
sample_accessions array · 208 items
[0]
GSM844917
[1]
GSM844918
[2]
GSM844919
[3]
GSM844920
[4]
GSM844921
[5]
GSM844922
[6]
GSM844923
[7]
GSM844924
[8]
GSM844925
[9]
GSM844926
[10]
GSM844927
[11]
GSM844928
[12]
GSM844929
[13]
GSM844930
[14]
GSM844931
[15]
GSM844932
[16]
GSM844933
[17]
GSM844934
[18]
GSM844935
[19]
GSM844936
[20]
GSM844937
[21]
GSM844938
[22]
GSM844939
[23]
GSM844940
[24]
GSM844941
[25]
GSM844942
[26]
GSM844943
[27]
GSM844944
[28]
GSM844945
[29]
GSM844946
[30]
GSM844947
[31]
GSM844948
[32]
GSM844949
[33]
GSM844950
[34]
GSM844951
[35]
GSM844952
[36]
GSM844953
[37]
GSM844954
[38]
GSM844955
[39]
GSM844956
[40]
GSM844957
[41]
GSM844958
[42]
GSM844959
[43]
GSM844960
[44]
GSM844961
[45]
GSM844962
[46]
GSM844963
[47]
GSM844964
[48]
GSM844965
[49]
GSM844966
[50]
GSM844967
[51]
GSM844968
[52]
GSM844969
[53]
GSM844970
[54]
GSM844971
[55]
GSM844972
[56]
GSM844973
[57]
GSM844974
[58]
GSM844975
[59]
GSM844976
[60]
GSM844977
[61]
GSM844978
[62]
GSM844979
[63]
GSM844980
[64]
GSM844981
[65]
GSM844982
[66]
GSM844983
[67]
GSM844984
[68]
GSM844985
[69]
GSM844986
[70]
GSM844987
[71]
GSM844988
[72]
GSM844989
[73]
GSM844990
[74]
GSM844991
[75]
GSM844992
[76]
GSM844993
[77]
GSM844994
[78]
GSM844995
[79]
GSM844996
[80]
GSM844997
[81]
GSM844998
[82]
GSM844999
[83]
GSM845000
[84]
GSM845001
[85]
GSM845002
[86]
GSM845003
[87]
GSM845004
[88]
GSM845005
[89]
GSM845006
[90]
GSM845007
[91]
GSM845008
[92]
GSM845009
[93]
GSM845010
[94]
GSM845011
[95]
GSM845012
[96]
GSM845013
[97]
GSM845014
[98]
GSM845015
[99]
GSM845016
[100]
GSM845017
[101]
GSM845018
[102]
GSM845019
[103]
GSM845020
[104]
GSM845021
[105]
GSM845022
[106]
GSM845023
[107]
GSM845024
[108]
GSM845025
[109]
GSM845026
[110]
GSM845027
[111]
GSM845028
[112]
GSM845029
[113]
GSM845030
[114]
GSM845031
[115]
GSM845032
[116]
GSM845033
[117]
GSM845034
[118]
GSM845035
[119]
GSM845036
[120]
GSM845037
[121]
GSM845038
[122]
GSM845039
[123]
GSM845040
[124]
GSM845041
[125]
GSM845042
[126]
GSM845043
[127]
GSM845044
[128]
GSM845045
[129]
GSM845046
[130]
GSM845047
[131]
GSM845048
[132]
GSM845049
[133]
GSM845050
[134]
GSM845051
[135]
GSM845052
[136]
GSM845053
[137]
GSM845054
[138]
GSM845055
[139]
GSM845056
[140]
GSM845057
[141]
GSM845058
[142]
GSM845059
[143]
GSM845060
[144]
GSM845061
[145]
GSM845062
[146]
GSM845063
[147]
GSM845064
[148]
GSM845065
[149]
GSM845066
[150]
GSM845067
[151]
GSM845068
[152]
GSM845069
[153]
GSM845070
[154]
GSM845071
[155]
GSM845072
[156]
GSM845073
[157]
GSM845074
[158]
GSM845075
[159]
GSM845076
[160]
GSM845077
[161]
GSM845078
[162]
GSM845079
[163]
GSM845080
[164]
GSM845081
[165]
GSM845082
[166]
GSM845083
[167]
GSM845084
[168]
GSM845085
[169]
GSM845086
[170]
GSM845087
[171]
GSM845088
[172]
GSM845089
[173]
GSM845090
[174]
GSM845091
[175]
GSM845092
[176]
GSM845093
[177]
GSM845094
[178]
GSM845095
[179]
GSM845096
[180]
GSM845097
[181]
GSM845098
[182]
GSM845099
[183]
GSM845100
[184]
GSM845101
[185]
GSM845102
[186]
GSM845103
[187]
GSM845104
[188]
GSM845105
[189]
GSM845106
[190]
GSM845107
[191]
GSM845108
[192]
GSM845109
[193]
GSM845110
[194]
GSM845111
[195]
GSM845112
[196]
GSM845113
[197]
GSM845114
[198]
GSM845115
[199]
GSM845116
[200]
GSM845117
[201]
GSM845118
[202]
GSM845119
[203]
GSM845120
[204]
GSM845121
[205]
GSM845122
[206]
GSM845123
[207]
GSM845124
sample_count
208
group_sizes
null
group_sizes_basis
null
platform
4133
taxon
Homo sapiens
title
Time-course gene expression profiles of gefitinib-sensitive or -resistant lung adenocarcinoma cells stimulated with EGF, in the presence or absence of gefitinib, EGF receptor tyrosine kinase-specific inhibitor
resolution_checked_at
2026-11-01T15:39:54Z
resolution_check
identifier_resolution_only_no_download_no_licence_read
downloaded
false
licence_read
false
gaps array · 2 items
[0]
asset:data:geo:GSE34228 not downloaded
[1]
asset:data:geo:GSE34228 licence not read
analysis object · 4 fields
state
partial
methods array · 5 items
[0] object · 10 fields
id
method-1
family
differential_expression
specific
limma_voom
label
Differential expression analysis
dsl_operations array · 3 items
[0]
normalise_counts
[1]
differential_expression_fit
[2]
fdr_bh
missing_operations array · 0 items
parameters object · 0 fields
data_shapes array · 1 item
[0]
count_matrix_with_condition
evidence object · 3 fields
score
0.7
band
medium
quote
limma
[1] object · 10 fields
id
method-2
family
network_analysis
specific
pathway_enrichment
label
Network / pathway analysis
dsl_operations array · 1 item
[0]
pathway_enrich
missing_operations array · 0 items
parameters object · 0 fields
data_shapes array · 1 item
[0]
edge_list
evidence object · 3 fields
score
0.7
band
medium
quote
GO enrichment
[2] object · 10 fields
id
method-3
family
contingency_analysis
specific
chi_square
label
Categorical (contingency table) analysis
dsl_operations array · 1 item
[0]
chi_square_test
missing_operations array · 0 items
parameters object · 0 fields
data_shapes array · 1 item
[0]
categorical_cross_tabulation
evidence object · 3 fields
score
0.8
band
high
quote
chi-square
[3] object · 10 fields
id
method-4
family
contingency_analysis
specific
fisher_exact
label
Categorical (contingency table) analysis
dsl_operations array · 2 items
[0]
contingency_table
[1]
chi_square_test
missing_operations array · 0 items
parameters object · 0 fields
data_shapes array · 1 item
[0]
categorical_cross_tabulation
evidence object · 3 fields
score
0.8
band
high
quote
Fisher's exact
[4] object · 10 fields
id
method-5
family
null
specific
null
label
Mann‒Whitney U test
dsl_operations array · 0 items
missing_operations array · 0 items
parameters object · 0 fields
data_shapes array · 0 items
evidence object · 3 fields
score
1
band
verbatim
quote
For continuous data that did not follow a normal distribution, the median (interquartile range) was used, and nonparametric tests, such as the Mann‒Whitney U test, were performed.
targets array · 0 items
gaps array · 1 item
[0]
method.reader_named_unmapped
capability object · 3 fields
state
complete
requirements array · 1 item
[0] object · 6 fields
capability_id
capability:computational_analysis
label
Computational analysis platform
assay_families array · 9 items
[0]
meta_analysis
[1]
machine_learning
[2]
survival_analysis
[3]
statistical_regression
[4]
pca
[5]
molecular_docking
[6]
network_analysis
[7]
differential_expression
[8]
gwas
candidate
Automated Assays Laravel application and simulated adapters
gaps array · 0 items
readiness object · 8 fields
state
complete
tier
R1
blocked_on
nothing:replicable_now
axes object · 3 fields
method object · 5 fields
tier
R1
expressible
true
required_operations array · 3 items
[0]
normalise_counts
[1]
differential_expression_fit
[2]
fdr_bh
missing_operations array · 0 items
basis
The paper names the method it used and the corpus's method extractor maps it onto the DSL catalogue: limma_voom.
capability object · 4 fields
tier
R1
capability_id
capability:computational_analysis
availability_state
owned
basis
The computational analysis is owned. The physical bench the paper used is not, so a physical validation cannot be run here.
data object · 6 fields
tier
R1
reachable
true
accessions array · 1 item
[0]
GSE34228
resolved_accessions array · 1 item
[0]
GSE34228
statements array · 1 item
[0]
The original contributions presented in the study are included in the article/Supplementary Materials. Further inquiries can be directed to the corresponding authors.
basis
The paper names GSE34228 in GEO and the accession resolves in the repository. No dataset was downloaded and no licence was read.
can_run object · 3 fields
dsl_operations array · 3 items
[0]
normalise_counts
[1]
differential_expression_fit
[2]
fdr_bh
assets array · 2 items
[0]
source:pmid:37990309
[1]
data:geo:GSE34228
steps array · 1 item
[0]
run_analysis
must_build object · 5 fields
dsl_operations array · 0 items
converters array · 0 items
readers array · 0 items
capabilities array · 0 items
data_gaps array · 1 item
[0]
data:geo:GSE34228
gaps array · 0 items
review object · 5 fields
state
partial
machine_critique object · 5 fields
kind
extraction_review
reader object · 5 fields
model
MiniMax-M3.1-Flash
provider
minimax
provider_family
minimax
read_at
2026-11-01T18:59:50Z
independence
single_reader
evidence_check object · 2 fields
method
verbatim
availability
verbatim
calls
5
usage object · 3 fields
prompt_tokens
17808
completion_tokens
1248
cached_tokens
264
stages array · 1 item
[0] object · 4 fields
id
extraction
state
complete
reader
MiniMax-M3.1-Flash
provider
minimax
gaps array · 3 items
[0]
review.independent_reader
[1]
review.machine_critique
[2]
review.human_critique
execution object · 5 fields
state
absent
status
not_run
mode
null
runs array · 0 items
gaps array · 1 item
[0]
execution.not_run
provenance object · 7 fields
entities array · 3 items
[0] object · 3 fields
id
pmid:37990309
type
paper
label
pmid:37990309
[1] object · 3 fields
id
source:pmid:37990309
type
manuscript
label
PMID 37990309 full text
[2] object · 3 fields
id
data:geo:GSE34228
type
dataset
label
GEO GSE34228
activities array · 3 items
[0] object · 4 fields
id
activity-reading-sci-2026-11-01
type
classification
used array · 3 items
[0] object · 3 fields
id
pmid:37990309
type
paper
label
pmid:37990309
[1] object · 3 fields
id
source:pmid:37990309
type
manuscript
label
PMID 37990309 full text
[2] object · 3 fields
id
data:geo:GSE34228
type
dataset
label
GEO GSE34228
agent
agent:corpus-assay-engine
[1] object · 4 fields
id
activity-read-37990309
type
extraction
used array · 1 item
[0]
source:pmid:37990309
agent
agent:minimax-reader
[2] object · 4 fields
id
activity-resolve-GSE34228
type
accession_resolution
used array · 1 item
[0]
data:geo:GSE34228
agent
agent:corpus-assay-engine
agents array · 2 items
[0] object · 3 fields
id
agent:corpus-assay-engine
type
software
label
Corpus assay engine
[1] object · 3 fields
id
agent:minimax-reader
type
software
label
MiniMax literature reader
source_run_id
reading-sci-2026-11-01
dsl_catalogue_fingerprint
343fb30756ba6ec3
capability_table_fingerprint
2cb3e42f047d2ecf
snapshot_id
ba34b49490d9bfaf
lineage object · 4 fields
parent_id
pmid:37990309
parent_hash
sha256:6d2b8f8771bb19e06fc1b74d289ea79459de6fcd93fba28943392894f36661ad
fork_of
null
gaps array · 7 items
[0]
asset:data:geo:GSE34228 licence not read
[1]
asset:data:geo:GSE34228 not downloaded
[2]
execution.not_run
[3]
method.reader_named_unmapped
[4]
review.human_critique
[5]
review.independent_reader
[6]
review.machine_critique
assays array · 2 items
[0] object · 11 fields
role
data_generation
definition_version
99e1195c7d6f
required_operations array · 0 items
support_state
partial
source_hashes object · 1 field
assay_lexicon
99e1195c7d6f
confidence
0.93
evidence array · 1 item
[0]
hological tissue specimens confirmed through real-time quantitative PCR to have an EGFR gene exon 19 deletion mutati
order_basis
paper_text_order:5285
id
assay:1
[1] object · 11 fields
role
analysis
definition_id
differential_expression
definition_version
f2132e96ae6c7a4e
required_operations array · 3 items
[0]
normalise_counts
[1]
differential_expression_fit
[2]
fdr_bh
support_state
supported
source_hashes object · 1 field
dsl_catalogue
f2132e96ae6c7a4e
evidence array · 1 item
[0]
limma
order_basis
consumes_earlier_output
id
assay:2
Complete file
{"sci_version": "1.2", "schema": "https://corpus.bntrg.co.uk/sci/1.0/sci.schema.json", "id": "pmid:37990309", "kind": "science-record", "revision": 3, "content_hash": "sha256:96a9e781903325cdd447e0c5640895b41dbed65402b495d05e5e40eeddb6a763", "created_at": "2026-11-01T19:02:55Z", "updated_at": "2026-11-01T22:10:43Z", "generator": {"name": "corpus-assay-engine", "run_id": "reading-sci-2026-11-01"}, "paper": {"state": "complete", "title": "A real-world study and network pharmacology analysis of EGFR-TKIs combined with ZLJT to delay drug resistance in advanced lung adenocarcinoma.", "doi": "10.1186/s12906-023-04213-3", "pmid": "37990309", "authors": ["Xue Han", "Lan Liang", "Chenming He", "Qinyou Ren", "Jialin Su", "Liang Cao", "Jin Zheng"], "journal": "BMC complementary medicine and therapies", "year": 2023, "abstract": "OBJECTIVE: This study aimed to explore the efficacy and safety of combining epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) with ZiLongJin Tablet (ZLJT) in delaying acquired resistance in advanced EGFR-mutant lung adenocarcinoma (LUAD) patients. Furthermore, we employed network pharmacology and molecular docking techniques to investigate the underlying mechanisms.\nMETHODS: A retrospective comparative study was conducted on stage IIIc/IV LUAD patients treated with EGFR-TKIs alone or in combination with ZLJT at the Second Affiliated Hospital of the Air Force Medical University between January 1, 2017, and May 1, 2023. The study evaluated the onset of TKI resistance, adverse reaction rates, safety indicators (such as aspartate aminotransferase, alanine aminotransferase, and creatinine), and inflammatory markers (neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio) to investigate the impact of EGFR-TKI combined with ZLJT on acquired resistance and prognostic indicators. Additionally, we utilized the Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform, the Bioinformatics Analysis Tool for Molecular Mechanism of Traditional Chinese Medicine, PubChem, UniProt, and Swiss Target Prediction databases to identify the active ingredients and targets of ZLJT. We obtained differentially expressed genes related to EGFR-TKI sensitivity and resistance from the Gene Expression Omnibus database using the GSE34228 dataset, which included sensitive (n = 26) and resistant (n = 26) PC9 cell lines. The \"limma\" package in R software was employed to detect DEGs. Based on this, we constructed a protein‒protein interaction network, performed gene ontology and KEGG enrichment analyses, and conducted pathway network analysis to elucidate the correlation between the active ingredients in ZLJT and signaling pathways. Finally, molecular docking was performed using AutoDockVina, PYMOL 2.2.0, and Discovery Studio Client v19.1.0 software to simulate spatial and energy matching during the recognition process between predicted targets and their corresponding compounds.\nRESULTS: (1) A total of 89 patients were included, with 40 patients in the EGFR-TKI combined with ZLJT group (combination group) and 49 patients in the EGFR-TKI alone group (monotherapy group). The baseline characteristics of the two groups were comparable. There was a significant difference in the onset of resistance between the combination group and the monotherapy group (P < 0.01). Compared to the monotherapy group, the combination group showed a prolongation of 3.27 months in delayed acquired resistance. There was also a statistically significant difference in the onset of resistance to first-generation TKIs between the two groups (P < 0.05). (2) In terms of safety analysis, the incidence of adverse reactions related to EGFR-TKIs was 12.5% in the combination group and 14.3% in the monotherapy group, but this difference was not statistically significant (P > 0.05). There were no statistically significant differences in serum AST, ALT, CREA, TBIL, ALB and BUN levels between the two groups after medication (P > 0.05). (3) Regarding inflammatory markers, there were no statistically significant differences in the changes in neutrophil-to-lymphocyte Ratio(NLR) and Platelet-to-lymphocyte Ratio(PLR) values before and after treatment between the two groups (P > 0.05). (4) Network pharmacology analysis identified 112 active ingredients and 290 target genes for ZLJT. From the GEO database, 2035 differentially expressed genes related to resistant LUAD were selected, and 39 target genes were obtained by taking the intersection. A \"ZLJT-compound-target-disease\" network was successfully constructed using Cytoscape 3.7.0. GO enrichment analysis revealed that ZLJT mainly affected biological processes such as adenylate cyclase-modulating G protein-coupled receptor. In terms of cellular components, ZLJT was associated with the cell projection membrane. The molecular function primarily focused on protein heterodimerization activity. KEGG enrichment analysis indicated that ZLJT exerted its antitumor and anti-drug resistance effects through pathways such as the PI3K-Akt pathway. Molecular docking showed that luteolin had good binding activity with FOS (-9.8 kJ/mol), as did tanshinone IIA with FOS (-9.8 kJ/mol) and quercetin with FOS (-8.7 kJ/mol).\nCONCLUSION: ZLJT has potential antitumor progression effects. For patients with EGFR gene-mutated non-small cell LUAD, combining ZLJT with EGFR-TKI treatment can delay the occurrence of acquired resistance. The underlying mechanisms may involve altering signal transduction pathways, blocking the tumor cell cycle, inhibiting tumor activity, enhancing cellular vitality, and improving the bioavailability of combination therapy. The combination of EGFR-TKI and ZLJT represents an effective approach for the treatment of tumors using both Chinese and Western medicine.", "claims": [{"id": "claim-method", "statement": "For continuous data that did not follow a normal distribution, the median (interquartile range) was used, and nonparametric tests, such as the Mann‒Whitney U test, were performed.", "kind": "methodological", "target": null, "evidence": [{"asset": "source:pmid:37990309", "locator": "sections[17] \"Statistical analysis of clinical data\" paragraph 2", "quote": "For continuous data that did not follow a normal distribution, the median (interquartile range) was used, and nonparametric tests, such as the Mann‒Whitney U test, were performed."}], "state": "complete"}, {"id": "claim-data-access", "statement": "The original contributions presented in the study are included in the article/Supplementary Materials. Further inquiries can be directed to the corresponding authors.", "kind": "methodological", "target": null, "evidence": [{"asset": "source:pmid:37990309", "locator": "sections[38] \"notes\" paragraph 1", "quote": "The original contributions presented in the study are included in the article/Supplementary Materials. Further inquiries can be directed to the corresponding authors."}], "state": "complete"}, {"id": "claim-target-result", "statement": "Compared with EGFR-TKI monotherapy, combination therapy with ZLJT prolonged the time to acquired resistance by 3.27 months (P < 0.01).", "kind": "qualitative", "target": null, "evidence": [{"asset": "source:pmid:37990309", "locator": "sections[0] \"Abstract\" paragraph 3", "quote": "Compared to the monotherapy group, the combination group showed a prolongation of 3.27 months in delayed acquired resistance."}], "state": "complete"}], "gaps": []}, "experiment": {"state": "complete", "objective": "Compared with EGFR-TKI monotherapy, combination therapy with ZLJT prolonged the time to acquired resistance by 3.27 months (P < 0.01).", "steps": [{"id": "read_published_estimate", "order": 1, "name": "Read the published estimate from the source", "kind": "other", "state": "complete", "blocked_on": null, "description": "The claim, method and evidence span published with the source article.", "duration_hours": null, "parameters": {}, "inputs": ["source:pmid:37990309"], "outputs": ["the published estimate and its evidence"], "instruments": [], "reagents": []}, {"id": "obtain_source_data", "order": 2, "name": "Obtain the source data from the named repository", "kind": "data-preparation", "state": "complete", "blocked_on": null, "description": "The GEO series accession resolves and its sample accessions are listed. This lane did not download the dataset or read its licence.", "duration_hours": null, "parameters": {}, "inputs": ["data:geo:GSE34228"], "outputs": ["the source data with its repository provenance"], "instruments": [], "reagents": []}, {"id": "run_analysis", "order": 3, "name": "Run the published analysis", "kind": "analysis", "state": "complete", "blocked_on": null, "description": "Apply the paper's statistical method to the resolved series and compare the result with the published target.", "duration_hours": null, "parameters": {}, "inputs": ["data:geo:GSE34228"], "outputs": ["the replicated result and its comparison"], "instruments": [], "reagents": []}], "materials": [], "instruments": [], "reagents": [], "conditions": {}, "gaps": []}, "data": {"state": "partial", "assets": [{"id": "source:pmid:37990309", "role": "manuscript", "format": "xml", "media_type": "application/xml", "uri": "https://doi.org/10.1186/s12906-023-04213-3", "sha256": "sha256:cb4e5f7efa84c91c3b43b2703b6dc67dce0a93aa0d30fb12ecd1331b2b50e201", "bytes": 63318, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "10.1186/s12906-023-04213-3", "version": null, "note": "Full article fetched from PMC; the checksum covers the rendered section body, not the original XML bytes.", "structure": {"pmcid": "PMC10664478", "source": "europe_pmc_fulltext", "coverage": "whole_body_without_references", "text_hash_scope": "rendered_section_body"}}, {"id": "data:geo:GSE34228", "role": "raw", "format": "geo-series", "media_type": "application/vnd.ncbi.geo-series+json", "uri": "https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE34228", "sha256": null, "bytes": null, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "GSE34228", "version": null, "note": "The original contributions presented in the study are included in the article/Supplementary Materials. Further inquiries can be directed to the corresponding authors.", "structure": {"repository": "GEO", "access_route": "GEO accession URL", "access_statement_verbatim": "The original contributions presented in the study are included in the article/Supplementary Materials. Further inquiries can be directed to the corresponding authors.", "access_statement_kind": "data_availability_statement", "sample_accessions": ["GSM844917", "GSM844918", "GSM844919", "GSM844920", "GSM844921", "GSM844922", "GSM844923", "GSM844924", "GSM844925", "GSM844926", "GSM844927", "GSM844928", "GSM844929", "GSM844930", "GSM844931", "GSM844932", "GSM844933", "GSM844934", "GSM844935", "GSM844936", "GSM844937", "GSM844938", "GSM844939", "GSM844940", "GSM844941", "GSM844942", "GSM844943", "GSM844944", "GSM844945", "GSM844946", "GSM844947", "GSM844948", "GSM844949", "GSM844950", "GSM844951", "GSM844952", "GSM844953", "GSM844954", "GSM844955", "GSM844956", "GSM844957", "GSM844958", "GSM844959", "GSM844960", "GSM844961", "GSM844962", "GSM844963", "GSM844964", "GSM844965", "GSM844966", "GSM844967", "GSM844968", "GSM844969", "GSM844970", "GSM844971", "GSM844972", "GSM844973", "GSM844974", "GSM844975", "GSM844976", "GSM844977", "GSM844978", "GSM844979", "GSM844980", "GSM844981", "GSM844982", "GSM844983", "GSM844984", "GSM844985", "GSM844986", "GSM844987", "GSM844988", "GSM844989", "GSM844990", "GSM844991", "GSM844992", "GSM844993", "GSM844994", "GSM844995", "GSM844996", "GSM844997", "GSM844998", "GSM844999", "GSM845000", "GSM845001", "GSM845002", "GSM845003", "GSM845004", "GSM845005", "GSM845006", "GSM845007", "GSM845008", "GSM845009", "GSM845010", "GSM845011", "GSM845012", "GSM845013", "GSM845014", "GSM845015", "GSM845016", "GSM845017", "GSM845018", "GSM845019", "GSM845020", "GSM845021", "GSM845022", "GSM845023", "GSM845024", "GSM845025", "GSM845026", "GSM845027", "GSM845028", "GSM845029", "GSM845030", "GSM845031", "GSM845032", "GSM845033", "GSM845034", "GSM845035", "GSM845036", "GSM845037", "GSM845038", "GSM845039", "GSM845040", "GSM845041", "GSM845042", "GSM845043", "GSM845044", "GSM845045", "GSM845046", "GSM845047", "GSM845048", "GSM845049", "GSM845050", "GSM845051", "GSM845052", "GSM845053", "GSM845054", "GSM845055", "GSM845056", "GSM845057", "GSM845058", "GSM845059", "GSM845060", "GSM845061", "GSM845062", "GSM845063", "GSM845064", "GSM845065", "GSM845066", "GSM845067", "GSM845068", "GSM845069", "GSM845070", "GSM845071", "GSM845072", "GSM845073", "GSM845074", "GSM845075", "GSM845076", "GSM845077", "GSM845078", "GSM845079", "GSM845080", "GSM845081", "GSM845082", "GSM845083", "GSM845084", "GSM845085", "GSM845086", "GSM845087", "GSM845088", "GSM845089", "GSM845090", "GSM845091", "GSM845092", "GSM845093", "GSM845094", "GSM845095", "GSM845096", "GSM845097", "GSM845098", "GSM845099", "GSM845100", "GSM845101", "GSM845102", "GSM845103", "GSM845104", "GSM845105", "GSM845106", "GSM845107", "GSM845108", "GSM845109", "GSM845110", "GSM845111", "GSM845112", "GSM845113", "GSM845114", "GSM845115", "GSM845116", "GSM845117", "GSM845118", "GSM845119", "GSM845120", "GSM845121", "GSM845122", "GSM845123", "GSM845124"], "sample_count": 208, "group_sizes": null, "group_sizes_basis": null, "platform": "4133", "taxon": "Homo sapiens", "title": "Time-course gene expression profiles of gefitinib-sensitive or -resistant lung adenocarcinoma cells stimulated with EGF, in the presence or absence of gefitinib, EGF receptor tyrosine kinase-specific inhibitor", "resolution_checked_at": "2026-11-01T15:39:54Z", "resolution_check": "identifier_resolution_only_no_download_no_licence_read", "downloaded": false, "licence_read": false}}], "gaps": ["asset:data:geo:GSE34228 not downloaded", "asset:data:geo:GSE34228 licence not read"]}, "analysis": {"state": "partial", "methods": [{"id": "method-1", "family": "differential_expression", "specific": "limma_voom", "label": "Differential expression analysis", "dsl_operations": ["normalise_counts", "differential_expression_fit", "fdr_bh"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["count_matrix_with_condition"], "evidence": {"score": 0.7, "band": "medium", "quote": "limma"}}, {"id": "method-2", "family": "network_analysis", "specific": "pathway_enrichment", "label": "Network / pathway analysis", "dsl_operations": ["pathway_enrich"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["edge_list"], "evidence": {"score": 0.7, "band": "medium", "quote": "GO enrichment"}}, {"id": "method-3", "family": "contingency_analysis", "specific": "chi_square", "label": "Categorical (contingency table) analysis", "dsl_operations": ["chi_square_test"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["categorical_cross_tabulation"], "evidence": {"score": 0.8, "band": "high", "quote": "chi-square"}}, {"id": "method-4", "family": "contingency_analysis", "specific": "fisher_exact", "label": "Categorical (contingency table) analysis", "dsl_operations": ["contingency_table", "chi_square_test"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["categorical_cross_tabulation"], "evidence": {"score": 0.8, "band": "high", "quote": "Fisher's exact"}}, {"id": "method-5", "family": null, "specific": null, "label": "Mann‒Whitney U test", "dsl_operations": [], "missing_operations": [], "expressible": null, "parameters": {}, "data_shapes": [], "evidence": {"score": 1.0, "band": "verbatim", "quote": "For continuous data that did not follow a normal distribution, the median (interquartile range) was used, and nonparametric tests, such as the Mann‒Whitney U test, were performed."}}], "targets": [], "gaps": ["method.reader_named_unmapped"]}, "capability": {"state": "complete", "requirements": [{"capability_id": "capability:computational_analysis", "label": "Computational analysis platform", "assay_families": ["meta_analysis", "machine_learning", "survival_analysis", "statistical_regression", "pca", "molecular_docking", "network_analysis", "differential_expression", "gwas"], "availability_state": "owned", "tier_unlocked": "R1", "candidate": "Automated Assays Laravel application and simulated adapters"}], "gaps": []}, "readiness": {"state": "complete", "tier": "R1", "blocking_axis": "none", "blocked_on": "nothing:replicable_now", "axes": {"method": {"tier": "R1", "expressible": true, "required_operations": ["normalise_counts", "differential_expression_fit", "fdr_bh"], "missing_operations": [], "basis": "The paper names the method it used and the corpus's method extractor maps it onto the DSL catalogue: limma_voom."}, "capability": {"tier": "R1", "capability_id": "capability:computational_analysis", "availability_state": "owned", "basis": "The computational analysis is owned. The physical bench the paper used is not, so a physical validation cannot be run here."}, "data": {"tier": "R1", "reachable": true, "accessions": ["GSE34228"], "resolved_accessions": ["GSE34228"], "statements": ["The original contributions presented in the study are included in the article/Supplementary Materials. Further inquiries can be directed to the corresponding authors."], "basis": "The paper names GSE34228 in GEO and the accession resolves in the repository. No dataset was downloaded and no licence was read."}}, "can_run": {"dsl_operations": ["normalise_counts", "differential_expression_fit", "fdr_bh"], "assets": ["source:pmid:37990309", "data:geo:GSE34228"], "steps": ["run_analysis"]}, "must_build": {"dsl_operations": [], "converters": [], "readers": [], "capabilities": [], "data_gaps": ["data:geo:GSE34228"]}, "gaps": []}, "review": {"state": "partial", "machine_critique": {"kind": "extraction_review", "reader": {"model": "MiniMax-M3.1-Flash", "provider": "minimax", "provider_family": "minimax", "read_at": "2026-11-01T18:59:50Z", "independence": "single_reader"}, "evidence_check": {"method": "verbatim", "availability": "verbatim"}, "calls": 5, "usage": {"prompt_tokens": 17808, "completion_tokens": 1248, "cached_tokens": 264}}, "human_critique": null, "stages": [{"id": "extraction", "state": "complete", "reader": "MiniMax-M3.1-Flash", "provider": "minimax"}], "gaps": ["review.independent_reader", "review.machine_critique", "review.human_critique"]}, "execution": {"state": "absent", "status": "not_run", "mode": null, "runs": [], "gaps": ["execution.not_run"]}, "provenance": {"entities": [{"id": "pmid:37990309", "type": "paper", "label": "pmid:37990309"}, {"id": "source:pmid:37990309", "type": "manuscript", "label": "PMID 37990309 full text"}, {"id": "data:geo:GSE34228", "type": "dataset", "label": "GEO GSE34228"}], "activities": [{"id": "activity-reading-sci-2026-11-01", "type": "classification", "used": [{"id": "pmid:37990309", "type": "paper", "label": "pmid:37990309"}, {"id": "source:pmid:37990309", "type": "manuscript", "label": "PMID 37990309 full text"}, {"id": "data:geo:GSE34228", "type": "dataset", "label": "GEO GSE34228"}], "agent": "agent:corpus-assay-engine"}, {"id": "activity-read-37990309", "type": "extraction", "used": ["source:pmid:37990309"], "agent": "agent:minimax-reader"}, {"id": "activity-resolve-GSE34228", "type": "accession_resolution", "used": ["data:geo:GSE34228"], "agent": "agent:corpus-assay-engine"}], "agents": [{"id": "agent:corpus-assay-engine", "type": "software", "label": "Corpus assay engine"}, {"id": "agent:minimax-reader", "type": "software", "label": "MiniMax literature reader"}], "source_run_id": "reading-sci-2026-11-01", "dsl_catalogue_fingerprint": "343fb30756ba6ec3", "capability_table_fingerprint": "2cb3e42f047d2ecf", "snapshot_id": "ba34b49490d9bfaf"}, "lineage": {"parent_id": "pmid:37990309", "parent_hash": "sha256:6d2b8f8771bb19e06fc1b74d289ea79459de6fcd93fba28943392894f36661ad", "fork_of": null, "generation": 2}, "gaps": ["asset:data:geo:GSE34228 licence not read", "asset:data:geo:GSE34228 not downloaded", "execution.not_run", "method.reader_named_unmapped", "review.human_critique", "review.independent_reader", "review.machine_critique"], "assays": [{"role": "data_generation", "definition_id": "qpcr", "definition_version": "99e1195c7d6f", "definition_digest": null, "required_operations": [], "support_state": "partial", "source_hashes": {"assay_lexicon": "99e1195c7d6f"}, "confidence": 0.93, "evidence": ["hological tissue specimens confirmed through real-time quantitative PCR to have an EGFR gene exon 19 deletion mutati"], "order_basis": "paper_text_order:5285", "id": "assay:1"}, {"role": "analysis", "definition_id": "differential_expression", "definition_version": "f2132e96ae6c7a4e", "definition_digest": null, "required_operations": ["normalise_counts", "differential_expression_fit", "fdr_bh"], "support_state": "supported", "source_hashes": {"dsl_catalogue": "f2132e96ae6c7a4e"}, "confidence": 0.7, "evidence": ["limma"], "order_basis": "consumes_earlier_output", "id": "assay:2"}]}